{"title":"An automatic COVID-19 CT segmentation based on Progressive encoder and decoder U-Net++ with attention mechanism","authors":"Xiaokang Ren, Jianwei Yang","doi":"10.1145/3570773.3570859","DOIUrl":"https://doi.org/10.1145/3570773.3570859","url":null,"abstract":"The coronavirus disease (COVID-19) pandemic has contribute to a harsh effect on the global public health. Computed Tomography (CT) is an effective tool in the screening of COVID-19. It is greater important to rapidly and accurately segment COVID-19 from CT to help diagnostic and monitor patients. In this paper, we propose a Progressive encoder and decoder U-Net++ based segmentation network using attention mechanism. In terms of COVID-19 lesion segmentation problems with highly imbalanced dataset and small regions of interests (ROI), we will use a progressive encoder and decoder combined with dilated convolution to form a deeper network structure, which can extract more and lower level semantic features while ensuring spatial information features. We propose to incorporate an attention mechanism to a progressive encoder and decoder U-Net++ architecture to capture rich contextual relationships for better feature representations. Meanwhile, the focal tversky loss is enhanced to address the small lesion segmentation. In addition, after combining the advantages of multiple modules, the network parameters will increase abruptly. According to the performance of the model in the validation set, we cut the redundant branch of the network model to do the final segmentation test, which can not only reduce the segmentation accuracy, but also reduce the network parameters and calculation cost. The experiment results, evaluated on a small dataset where only 3520 CT images are available, prove the enhanced model can achieve an accurate result on COVID-19 segmentation. The obtained Dice Score, Sensitivity and Specificity are 70.1%, 82.1%, and 92.3%, respectively.","PeriodicalId":153475,"journal":{"name":"Proceedings of the 3rd International Symposium on Artificial Intelligence for Medicine Sciences","volume":"136 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122057727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Discussions of Chemical, Biological, and Economic Features of two FDA Authorized Antivirals Against COVID-19: Molnupiravir and Paxlovid","authors":"Jiaqi Dong","doi":"10.1145/3570773.3570807","DOIUrl":"https://doi.org/10.1145/3570773.3570807","url":null,"abstract":"Molnupiravir from Merck and Paxlovid from Pfizer are both promising. Since December 2019, the COVID-19 pandemic due to infection of SARS-CoV-2 has posed a challenge to global healthcare systems. Although vaccines and potential treatments have been developed, there are still many unknown areas of this virus, and people are still searching for efficient ways to treat the disease. Recently, two oral antivirals for COVID-19, Molnupiravir from Merck and Paxlovid from Pfizer, were developed and given emergency use authorization (EUA) from the U.S. FDA to reduce hospitalizations and death from COVID-19. Though the mechanism of action of the two drugs is very different, both drugs have shown promising efficacy in treating COVID-19 infections. This paper will compare these two drugs in various aspects, including their chemical structures, mechanism of action, efficacy and safety, and drug economics.","PeriodicalId":153475,"journal":{"name":"Proceedings of the 3rd International Symposium on Artificial Intelligence for Medicine Sciences","volume":"11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117131814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Lightweight Lung Region Image Segmentation Model with Attention Mechanisms","authors":"Furong Cai, Yingguang Hao, Hongyu Wang","doi":"10.1145/3570773.3570809","DOIUrl":"https://doi.org/10.1145/3570773.3570809","url":null,"abstract":"Image segmentation of lung regions is helpful for the diagnosis of lung diseases. The existing lung segmentation networks with high segmentation accuracy face difficulty in leveraging accuracy and speed in practical clinical application platforms due to high computational loads. To address this issue, we propose a lightweight lung segmentation network based on U-Net, which consists of a residual depth-separable module, an attention module, and a multi-receptive field feature fusion module. Depthwise separable convolutions are used to achieve lightweight. To prevent a drop in accuracy, we add a scSE attention module to the encoder to help the model effectively highlight the target area during feature extraction and pay more attention to the foreground pixels. In addition, a lightweight multi-receptive field feature fusion module is designed to alleviate the loss of spatial information caused by pooling and better adapt to the multi-size features of the lung region. The proposed network is evaluated on the Luna16 and the NSCLC-Radiomics datasets. Compared with the standard U-Net model, the proposed model maintains the original accuracy and reduces the number of parameters by 69.3%.","PeriodicalId":153475,"journal":{"name":"Proceedings of the 3rd International Symposium on Artificial Intelligence for Medicine Sciences","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126266318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Convolutional neural network-based image recognition for animals","authors":"He Huang","doi":"10.1145/3570773.3570832","DOIUrl":"https://doi.org/10.1145/3570773.3570832","url":null,"abstract":"In this paper, the basic of convolutional neural network (CNN) and machine learning (ML) was introduced firstly. With the help of TensorFlow, a model building tool, including how they work together to process an image and extract the basic information of it, 25000 images were used including both cats and dogs to train the CNN, which makes the differences between cats and dogs accessible, therefore identifying the cats and dogs. After training the program with such data sets, this work calculated the probability of correctly identifying the animals in the image and finally analyzed it by using the existing data sets.","PeriodicalId":153475,"journal":{"name":"Proceedings of the 3rd International Symposium on Artificial Intelligence for Medicine Sciences","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126336059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Universal CAR-T Generated Using the One-shot CRISPR/Cas9 System as a Replacement for Conventional Patient-specific CAR-T Therapy for B-Cell Acute Lymphoblastic Leukemia","authors":"U. H. Chan","doi":"10.1145/3570773.3570788","DOIUrl":"https://doi.org/10.1145/3570773.3570788","url":null,"abstract":"Since the traditional patient-specific CAR-T has an obvious disadvantage of long wait time while universal CAR-T has a risk of graft rejection. This experiment will investigate the safety and efficacy of the enhanced universal CAR-T generated using the one-hit CRISPR/Cas9 system and the traditional CAR-T in humanized-leukemic mice. Mice are first humanized by transplantation of human fetal thymus CD34+ liver cells of two origins. B-ALL cells are extracted from mice transduced with MLL-AF9 fusion gene/GFP-carrying retroviruses. T cells are extracted from mice and anti-CD19 CAR-T are generated by lentiviral transduction. They are transplanted into autologous mice. Other T cells extracted undergo TCR/HLA-I/Fas-triple gene ablation using one-shot CRISPR protocols and transplanted into allogenic mice. Three measurements are taken at day 1, 3, 7, 14, 21, and 28 post-transplantation: anti-CD19 CAR-T serum level by flow cytometry; CD19+GFP+ PBMC serum level by FACS, and acute GVHD-related biomarker expression (IL-2Rα, TNFR-1, IL- 8, HGF) by ELISA assay. There are 8 possible results but only when the universal CAR-grafted mice express a significantly higher serum level of CAR-T and a significant increase in the killing of leukemic cells while showing no indication of graft rejection risk, then would the result support the hypothesis. The experimental design of this study can be used as a reference for future research on universal CAR-T in mice. The results of this experiment provide important insight into the safety and efficacy of universal CAR-T; and aids in the clinical translation of this technology.","PeriodicalId":153475,"journal":{"name":"Proceedings of the 3rd International Symposium on Artificial Intelligence for Medicine Sciences","volume":"44 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134554364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yang Chen, Minqi Chen, Yijun Chen, Wenjun Mao, Yijing Wang
{"title":"High Exogenous Cholesterol Level Suppress the HMGCR Expression in MVA Pathway and it's Relationship with Ferroptosis in Colorectal Cancer cell","authors":"Yang Chen, Minqi Chen, Yijun Chen, Wenjun Mao, Yijing Wang","doi":"10.1145/3570773.3570806","DOIUrl":"https://doi.org/10.1145/3570773.3570806","url":null,"abstract":"Ferroptosis is a type of programmed cell death that can be regulated in many pathways to interfere with the development of many diseases such as tumors. Based on the recent years study, the mevalonate (MVA) pathway has been discovered to be one of the significant regulatory factors of ferroptosis. In addition, hydroxymethylglutaryl coenzyme A reductase (HMGCR), a crucial regulatory enzyme manipulating the biosynthesis of endogenous cholesterol, found out to be the rate-limiting enzyme of MVA pathway by previous studies. However, despite HMGCR being known to be highly contributing to cholesterol biosynthesis, interplay of MVA pathway and HMGCR expression affected by the cholesterol level remains unexplored. In this research, we focused on colorectal cancer by using HT29 cell line as the target of study and we hypothesize that by increasing the concentration of exogenous cholesterol inhibit HMGCR will lead to the production of inhibitory effect on MVA Pathway. Isopentenyl Pyrophosphate (IPP) is an important product of the MVA Pathway, which the inhibition of MVA Pathway will result in the decrease of IPP production. The decrease of IPP production is impeding Selenocysteine tRNA maturation and downregulating the synthesis of Selenocysteine tRNA, which in turn is affecting Glutathione Peroxidase 4 (GPX4) activity. The GPX4 and Ferroptosis are also closely connected, so if GPX4 is inhibited, Ferroptosis is likely to occur and thus affect the progression of Colorectal cancer. With a more in depth understanding of the mevalonate pathway and its relationship with ferroptosis, it could propose a new target for antitumor treatment development in the future.","PeriodicalId":153475,"journal":{"name":"Proceedings of the 3rd International Symposium on Artificial Intelligence for Medicine Sciences","volume":"49 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133217496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Construction and Application of Whole Assembly Operating Room in Medical Construction","authors":"Xiwei Li","doi":"10.1145/3570773.3570874","DOIUrl":"https://doi.org/10.1145/3570773.3570874","url":null,"abstract":"In order to improve the construction speed and quality of clean operation department, a design scheme of whole assembly operating room is put forward. Aiming at the problems of low construction efficiency and many welding operations in the traditional operating room, the clean room construction is divided into several functional modules, such as decoration, purification, HVAC and electrical intelligence. The modules are produced in the factory, and the on-site functions are reserved. Through the organic combination of each functional module, the construction of an operating room environment is quickly completed. It has formed a new construction technology of integrated assembled medical clean room, which meets the requirements of healthy, comfortable, green, environmentally friendly, intelligent and efficient assembled medical clean room.","PeriodicalId":153475,"journal":{"name":"Proceedings of the 3rd International Symposium on Artificial Intelligence for Medicine Sciences","volume":"43 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133286139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Scheduling with periodic due date to minimize the maximum tardiness in lean production of medical equipment","authors":"Zhouli He, Xiaolong Cui, Hongyu Huang, Long Wan","doi":"10.1145/3570773.3570812","DOIUrl":"https://doi.org/10.1145/3570773.3570812","url":null,"abstract":"In the paper, we study the scheduling problem in single-machine and parallel-machine environment in lean production of medical equipment. We no longer follow the exploration idea of scheduling problems under the traditional duration rules, and no longer set the duration of a job as its own attribute, that is, we no longer specifically set the duration of a job one by one, but specify it by the sequencing position of the jobs in the specific scheduling scheme. And the interval length between two consecutive construction due dates is equal. This rule is called periodic due dates. The goal we are considering is to minimize the maximum tardiness. For single-machine environment, we give an optimal schedule in polynomial time; for two parallel-machine environment, we demonstrated the problem is binary NP-hard; for parallel-machine environment, we prove the problem is strong NP-hard.","PeriodicalId":153475,"journal":{"name":"Proceedings of the 3rd International Symposium on Artificial Intelligence for Medicine Sciences","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115592458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Does OTC inhibited glutamate uptake by GLAST and GLT-1?","authors":"J. Yuan","doi":"10.1145/3570773.3570811","DOIUrl":"https://doi.org/10.1145/3570773.3570811","url":null,"abstract":"Ochratoxin A, a naturally occurring toxin that is produced by fungi and proven to be able to cause nephrotoxic, teratogenic, and carcinogenic problems via oxidative DNA damage. Ochratoxin C is proven to be able to convert into Ochratoxin A in mice, which also inhibits the absorption of glutamate by astrocytes through a decrease in cell surface expression of the excitatory amino-acid transporters GLAST and GLT-1. This paper is to explore the influence of different amounts of Ochratoxin C treating different types of mice, while measuring glutamate or glutamine uptake in neurons. Investigate Ochratoxin C affinity column pulldown to check for interaction between Ochratoxin C and GLAST or GLT1. In this paper, study will show whether the Ochratoxin C shows the same reaction of Ochratoxin A, showing that Ochratoxin C should get more attention on the future clinical trial just like Ochratoxin A. Further studies will focus on the regulation of Ochratoxin C to see if Ochratoxin A could be regulated as well when they could be converted.","PeriodicalId":153475,"journal":{"name":"Proceedings of the 3rd International Symposium on Artificial Intelligence for Medicine Sciences","volume":"101 41","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"120826040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rikang Huang, Lingyi Xin, Yan Yang, Zelong Wang, Long Ma, Ying He
{"title":"Preparation and evaluation of ginseng whitening and nourishing mask","authors":"Rikang Huang, Lingyi Xin, Yan Yang, Zelong Wang, Long Ma, Ying He","doi":"10.1145/3570773.3570785","DOIUrl":"https://doi.org/10.1145/3570773.3570785","url":null,"abstract":"A facial mask was prepared with ginseng extract as the main raw material, and its quality and safety were evaluated. Ginseng and other four traditional Chinese medicine extracts were prepared by reflux extraction, ultrasonic extraction and decoction. Screening the dosage of auxiliary materials by viscosity, moisture retention rate and other indicators; Tyrosinase inhibition rate, DPPH free radical scavenging rate and superoxide anion inhibition rate were used as inspection indexes to determine the best formula of facial mask. The quality of facial mask was evaluated by sensory index, physical and chemical index, hygienic standard and microbial limit. The safety of facial mask was evaluated by skin irritation test and acute eye irritation test. The results showed that the ginseng whitening and nourishing mask had good whitening and antioxidant effects. The quality of this mask meets the quality standard, and the safety evaluation shows that it has mild skin effect and no obvious irritation.","PeriodicalId":153475,"journal":{"name":"Proceedings of the 3rd International Symposium on Artificial Intelligence for Medicine Sciences","volume":"31 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127209575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}